Case Report

The Journal of the Korean Rheumatism Association 2005; 12(3): 240-244

Published online September 30, 2005

© Korean College of Rheumatology

형질세포종에서 병발된 강직성 척추염 1예

김용남·이향이·이상훈·이연아·우두현·황보영·조경삼*·박용구**·양형인

경희대학교 의과대학 내과학교실 류마티스내과, 종양혈액내과*, 병리학교실**

Ankylosing Spondylitis associated with Plasmacytoma: a Case Report

Yong-Nam Kim, Hyang-Ee Lee, Sang-Hoon Lee, Yeon-A Lee, Doo-Hyun Woo, Young Hwangbo, Kyung-Sam Cho*, Yong-Koo Park**, Hyung-In Yang

Division of Rheumatology, Department of Internal Medicine, Division of Hematooncology*, Department of Internal Medicine and Department of Pathology**, Kyunghee University School of Medicine, Seoul, Korea

Correspondence to : Hyung-In Yang

Abstract

Plasmacytomas are tumors composed of plasma cells of variable maturity, which are histologically identical to those seen in multiple myeloma. Ankylosing spondylitis is a chronic inflammatory disease, probably resulting from the interaction of a genetic predisposition involving HLA-B27 with an environmental event such as enteric bacterial infection. Multiple myeloma has been intermittently reported in patients with ankylosing spondylitis. It has been proposed that the protracted stimulation of immunocytes by inflammatory lesions on the mucosal surfaces of the gastrointestinal, respiratory tracts may be implicated in the pathogenesis of multiple myeloma in some patients. We observed a 23 year old male patient with a history of plasmacytoma who subsequently developed ankylosing spondylitis. He was diagnosed as plasmacytoma 4 years ago and took a radiation therapy. There was no previous report of ankylosing spondylitis following plasmacytoma. The relationship between two diseases is uncertain until now and further study should be needed.

Keywords Multiple myeloma, Plasmacytoma, Ankylosing spondylitis

Article

Case Report

The Journal of the Korean Rheumatism Association 2005; 12(3): 240-244

Published online September 30, 2005

Copyright © Korean College of Rheumatology.

형질세포종에서 병발된 강직성 척추염 1예

김용남·이향이·이상훈·이연아·우두현·황보영·조경삼*·박용구**·양형인

경희대학교 의과대학 내과학교실 류마티스내과, 종양혈액내과*, 병리학교실**

Ankylosing Spondylitis associated with Plasmacytoma: a Case Report

Yong-Nam Kim, Hyang-Ee Lee, Sang-Hoon Lee, Yeon-A Lee, Doo-Hyun Woo, Young Hwangbo, Kyung-Sam Cho*, Yong-Koo Park**, Hyung-In Yang

Division of Rheumatology, Department of Internal Medicine, Division of Hematooncology*, Department of Internal Medicine and Department of Pathology**, Kyunghee University School of Medicine, Seoul, Korea

Correspondence to:Hyung-In Yang

Abstract

Plasmacytomas are tumors composed of plasma cells of variable maturity, which are histologically identical to those seen in multiple myeloma. Ankylosing spondylitis is a chronic inflammatory disease, probably resulting from the interaction of a genetic predisposition involving HLA-B27 with an environmental event such as enteric bacterial infection. Multiple myeloma has been intermittently reported in patients with ankylosing spondylitis. It has been proposed that the protracted stimulation of immunocytes by inflammatory lesions on the mucosal surfaces of the gastrointestinal, respiratory tracts may be implicated in the pathogenesis of multiple myeloma in some patients. We observed a 23 year old male patient with a history of plasmacytoma who subsequently developed ankylosing spondylitis. He was diagnosed as plasmacytoma 4 years ago and took a radiation therapy. There was no previous report of ankylosing spondylitis following plasmacytoma. The relationship between two diseases is uncertain until now and further study should be needed.

Keywords: Multiple myeloma, Plasmacytoma, Ankylosing spondylitis

JRD
Oct 01, 2024 Vol.31 No.4, pp. 191~263
COVER PICTURE
Ancestry-driven pathways for SLE-risk SNP-associated genes. The ancestry-driven key signaling pathways in Asians, Europeans, and African Americans were analyzed by enrichr (https://maayanlab.cloud/Enrichr/#libraries) using non-HLA SNP-associated genes. SLE: systemic lupus erythematosus, SNP: single-nucleotide polymorphism, JAK–STAT: janus kinase–signal transducers and activators of transcription, IFN: interferon gamma. (J Rheum Dis 2024;31:200-211)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download